Andrey V. Sapegin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrey V. Sapegin has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Vladimirovich Bogachev-Prokophiev
Meshalkin National Medical Research Center
4 shared publications - Ravil M. Sharifulin
Meshalkin National Medical Research Center
4 shared publications - Alexander V. Afanasyev
Meshalkin National Medical Research Center Novosibirsk Russian Federation
3 shared publications - S. I. Zheleznev
Meshalkin National Medical Research Center
3 shared publications - A. S. Zalesov
Meshalkin National Medical Research Center
2 shared publications - Marina A. Ovchinnikova
Meshalkin National Medical Research Center
2 shared publications
Latest Publications
- 18 February 2026
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 19 (1)
Modern aspects in surgical treatment of atrial fibrillation with simultaneous mitral valve surgery via minimally invasive approach: evolution of techniques and analysis of clinical outcomes
Objective. To analyze the efficacy and specific features of surgical treatment of atrial fibrillation (AF) in mitral valve surgery via minimally invasive approach, as well as to compare the outcomes with those after conventional sternotomy. Material and methods. A systematic literature searching was conducted in the following electronic databases from their inception until June 2025: Ovid MEDLINE, EMBASE, and SCOPUS. The review examines modern atrial ablation techniques, including cryo- and radiofrequency ablation, as well as left atrial appendage exclusion methods. Comparative studies evaluating the effectiveness of minimally invasive versus standard approaches were analyzed. The authors focused on freedom from AF, complication rates and postoperative mortality. Results. Minimally invasive techniques demonstrate efficacy comparable to traditional approaches in AF treatment with freedom from atrial arrhythmias ranging from 78% to 99% within a year. Advantages of minimally invasive approach include shorter recovery time, lower complication rates (6% vs. 13%), and reduced need for pacemaker implantation (4% vs. 18%), as reported by various authors. Technological advancements in thermal ablation devices have improved precision and safety of procedures. Conclusion. Minimally invasive approach is a safe and effective alternative to conventional sternotomy for surgical treatment of AF combined with mitral valve repair. Further research should focus on optimizing techniques, refining patient selection criteria, and evaluating long-term outcomes.
- 18 February 2026
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 19 (1)
Modern aspects in surgical treatment of atrial fibrillation with simultaneous mitral valve surgery via minimally invasive approach: evolution of techniques and analysis of clinical outcomes
Objective. To analyze the efficacy and specific features of surgical treatment of atrial fibrillation (AF) in mitral valve surgery via minimally invasive approach, as well as to compare the outcomes with those after conventional sternotomy. Material and methods. A systematic literature searching was conducted in the following electronic databases from their inception until June 2025: Ovid MEDLINE, EMBASE, and SCOPUS. The review examines modern atrial ablation techniques, including cryo- and radiofrequency ablation, as well as left atrial appendage exclusion methods. Comparative studies evaluating the effectiveness of minimally invasive versus standard approaches were analyzed. The authors focused on freedom from AF, complication rates and postoperative mortality. Results. Minimally invasive techniques demonstrate efficacy comparable to traditional approaches in AF treatment with freedom from atrial arrhythmias ranging from 78% to 99% within a year. Advantages of minimally invasive approach include shorter recovery time, lower complication rates (6% vs. 13%), and reduced need for pacemaker implantation (4% vs. 18%), as reported by various authors. Technological advancements in thermal ablation devices have improved precision and safety of procedures. Conclusion. Minimally invasive approach is a safe and effective alternative to conventional sternotomy for surgical treatment of AF combined with mitral valve repair. Further research should focus on optimizing techniques, refining patient selection criteria, and evaluating long-term outcomes.
- 3 June 2024
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 32 (5) , 285-293
Minimally invasive versus conventional methods for aortic root surgery: Choosing the right approach
Objective: Partial upper sternotomy is preferred for isolated aortic valve replacement because of its optimal surgical visibility and favorable cosmetic outcomes; however, it is not commonly used for aortic root surgery, and the conventional median sternotomy is still the preferred method for most surgeons. We aimed to compare the safety and effectiveness of a minimally invasive approach (partial sternotomy [PS]) and conventional approach (median sternotomy [FS]) for aortic root surgery. Methods: Patients who underwent aortic root surgery at our hospital from 2016 to 2021 were retrospectively enrolled and divided into two groups. After propensity score matching, the conventional group included 156 patients and the minimally invasive group—57 patients. Results: Bicuspid aortic valves were observed in 63 (40.4%) and 33 (57.9%) patients in the FS and PS groups, respectively. Valve-sparing surgery was performed on 69 (44.2%) and 30 (52.6%) patients in the FS and PS groups, respectively. The minimally invasive approach was beneficial in terms of blood loss during the first 24 h after surgery ( p = 0.029) and postoperative blood transfusion ( p = 0.023). The survival rates and freedom from reoperation or severe aortic regurgitation after the David procedure were comparable between the standard and minimally invasive groups ( p = 0.25; p = 0.66) at mid-term follow-up. Conclusions: A minimally invasive approach for aortic root surgery can be safely performed as the standard approach. Partial upper sternotomy has the advantage of lower blood loss in the early postoperative period and does not negatively affect the results of valve-sparing root replacement.
- 3 June 2024
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 32 (5) , 285-293
Minimally invasive versus conventional methods for aortic root surgery: Choosing the right approach
Objective: Partial upper sternotomy is preferred for isolated aortic valve replacement because of its optimal surgical visibility and favorable cosmetic outcomes; however, it is not commonly used for aortic root surgery, and the conventional median sternotomy is still the preferred method for most surgeons. We aimed to compare the safety and effectiveness of a minimally invasive approach (partial sternotomy [PS]) and conventional approach (median sternotomy [FS]) for aortic root surgery. Methods: Patients who underwent aortic root surgery at our hospital from 2016 to 2021 were retrospectively enrolled and divided into two groups. After propensity score matching, the conventional group included 156 patients and the minimally invasive group—57 patients. Results: Bicuspid aortic valves were observed in 63 (40.4%) and 33 (57.9%) patients in the FS and PS groups, respectively. Valve-sparing surgery was performed on 69 (44.2%) and 30 (52.6%) patients in the FS and PS groups, respectively. The minimally invasive approach was beneficial in terms of blood loss during the first 24 h after surgery ( p = 0.029) and postoperative blood transfusion ( p = 0.023). The survival rates and freedom from reoperation or severe aortic regurgitation after the David procedure were comparable between the standard and minimally invasive groups ( p = 0.25; p = 0.66) at mid-term follow-up. Conclusions: A minimally invasive approach for aortic root surgery can be safely performed as the standard approach. Partial upper sternotomy has the advantage of lower blood loss in the early postoperative period and does not negatively affect the results of valve-sparing root replacement.
- 1 December 2021
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 30 (12) , 1949-1957
Rigid Ring Versus Flexible Band for Tricuspid Valve Repair in Patients Scheduled for Mitral Valve Surgery: A Prospective Randomised Study
- 1 December 2021
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 30 (12) , 1949-1957
Rigid Ring Versus Flexible Band for Tricuspid Valve Repair in Patients Scheduled for Mitral Valve Surgery: A Prospective Randomised Study
- Open Access
- 28 September 2021
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 25 (3) , 51-60
Short-term outcomes of surgical atrial ablation and septal myectomy
Background. Hypertrophic cardiomyopathy is one of the most common types of cardiomyopathy. The appearance of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy is associated with significant clinical worsening. Outcomes of surgical ablation and septal myectomy in these patients are limited.Aim. This retrospective study aimed to evaluate short-term outcomes of concomitant surgical ablation and septal myectomy in patients with obstructive hypertrophic cardiomyopathy and atrial fibrillation.Methods. Fifty-five patients with hypertrophic obstructive cardiomyopathy and atrial fibrillation who underwent concomitant surgical ablation and septal myectomy between 2014 and 2019 were analysed. Patients with paroxysmal atrial fibrillation predominantly underwent left atrial ablation, and those with nonparoxysmal atrial fibrillation predominantly underwent the Maze IV procedure. Surgical ablation was performed using cryoablation alone (83.6%) or in combination with radiofrequency energy (16.4%).Results. Hospital mortality was 1.8%. Incidence of major adverse events was 3.6%. Sinus node dysfunction and atrioventricular block occurred in 7.3% and 1.8% of patients, respectively. Bleeding requiring revision occurred in 2 (3.6%) patients. Forty-nine (89.1%) patients had stable sinus rhythm and five (9.1%) were on dual-chamber pacemaker stimulation at the time of discharge.Conclusion. Concomitant septal myectomy and surgical ablation are feasible and safe in patients with hypertrophic obstructive cardiomyopathy and atrial fibrillation.Received 5 April 2021. Revised 16 May 2021. Accepted 17 May 2021.Funding: The study did not have sponsorship.Conflict of interest: The authors declare no conflicts of interests.Contribution of the authorsConception and study design: A.S. Zalesov, A.V. Bogachev-ProkophievData collection and analysis: A.S. Zalesov, S.A. Budagaev, A.V. SapeginStatistical analysis: A.S. Zalesov, A.V. Afanasyev, R.M. SharifulinDrafting the article: A.S. ZalesovCritical revision of the article: A.V. Bogachev-Prokophiev, S.I. Zheleznev, I.I. DeminFinal approval of the version to be published: A.S. Zalesov, A.V. Bogachev-Prokophiev, A.V. Afanasyev, R.M. Sharifulin, A.V. Sapegin, S.A. Budagaev, S.I. Zheleznev, I.I. Demin
- 28 September 2021
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 25 (3) , 51-60
Open AccessShort-term outcomes of surgical atrial ablation and septal myectomy
Background. Hypertrophic cardiomyopathy is one of the most common types of cardiomyopathy. The appearance of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy is associated with significant clinical worsening. Outcomes of surgical ablation and septal myectomy in these patients are limited.Aim. This retrospective study aimed to evaluate short-term outcomes of concomitant surgical ablation and septal myectomy in patients with obstructive hypertrophic cardiomyopathy and atrial fibrillation.Methods. Fifty-five patients with hypertrophic obstructive cardiomyopathy and atrial fibrillation who underwent concomitant surgical ablation and septal myectomy between 2014 and 2019 were analysed. Patients with paroxysmal atrial fibrillation predominantly underwent left atrial ablation, and those with nonparoxysmal atrial fibrillation predominantly underwent the Maze IV procedure. Surgical ablation was performed using cryoablation alone (83.6%) or in combination with radiofrequency energy (16.4%).Results. Hospital mortality was 1.8%. Incidence of major adverse events was 3.6%. Sinus node dysfunction and atrioventricular block occurred in 7.3% and 1.8% of patients, respectively. Bleeding requiring revision occurred in 2 (3.6%) patients. Forty-nine (89.1%) patients had stable sinus rhythm and five (9.1%) were on dual-chamber pacemaker stimulation at the time of discharge.Conclusion. Concomitant septal myectomy and surgical ablation are feasible and safe in patients with hypertrophic obstructive cardiomyopathy and atrial fibrillation.Received 5 April 2021. Revised 16 May 2021. Accepted 17 May 2021.Funding: The study did not have sponsorship.Conflict of interest: The authors declare no conflicts of interests.Contribution of the authorsConception and study design: A.S. Zalesov, A.V. Bogachev-ProkophievData collection and analysis: A.S. Zalesov, S.A. Budagaev, A.V. SapeginStatistical analysis: A.S. Zalesov, A.V. Afanasyev, R.M. SharifulinDrafting the article: A.S. ZalesovCritical revision of the article: A.V. Bogachev-Prokophiev, S.I. Zheleznev, I.I. DeminFinal approval of the version to be published: A.S. Zalesov, A.V. Bogachev-Prokophiev, A.V. Afanasyev, R.M. Sharifulin, A.V. Sapegin, S.A. Budagaev, S.I. Zheleznev, I.I. Demin
- Open Access
- 4 September 2021
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (8) , 4565
Meshalkin National Medical Research Center
We present three cases of successful transatrial transcatheter valve-in-valve implantation in patients with bioprosthetic mitral valve dysfunction. Patients with a high surgical risk, with severe heart failure due to bioprosthetic mitral valve dysfunction, were implanted with transcatheter prostheses using the transatrial approach.Transesophageal echocardiography and fluoroscopy-guided transcatheter mitral prosthetic valve positioning was performed. With a cardiac pacing at 180 bpm, a transcatheter valve was implanted. The transcatheter valves functioned properly after surgery. The patients were discharged in satisfactory condition.
- 4 September 2021
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (8) , 4565
Open AccessMeshalkin National Medical Research Center
We present three cases of successful transatrial transcatheter valve-in-valve implantation in patients with bioprosthetic mitral valve dysfunction. Patients with a high surgical risk, with severe heart failure due to bioprosthetic mitral valve dysfunction, were implanted with transcatheter prostheses using the transatrial approach.Transesophageal echocardiography and fluoroscopy-guided transcatheter mitral prosthetic valve positioning was performed. With a cardiac pacing at 180 bpm, a transcatheter valve was implanted. The transcatheter valves functioned properly after surgery. The patients were discharged in satisfactory condition.
- Open Access
- 14 September 2020
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 25 (8) , 3847
First experience of transcatheter implantation of a Russian-made MedLab-CT prosthesis in a patient with dysfunction of biological mitral valve prosthesis
We present a case report of successful transcatheter implantation of a Russian-made cardiac valve prosthesis in a patient with dysfunction of biological mitral valve prosthesis (valve-in-valve). A patient aged 78 years with a high surgical risk and severe heart failure due to mitral valve bioprosthesis dysfunction is described. Fluoroscopyand transesophageal echocardiography-guided transapical implantation of a MedLab-CT prosthesis (23 mm) was made. When a heart rate of 180 beats per minute, a stent prosthesis was implanted. Transcatheter implant valve functioned properly after surgery. The patient was discharged in satisfactory condition.
- 14 September 2020
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 25 (8) , 3847
Open AccessFirst experience of transcatheter implantation of a Russian-made MedLab-CT prosthesis in a patient with dysfunction of biological mitral valve prosthesis
We present a case report of successful transcatheter implantation of a Russian-made cardiac valve prosthesis in a patient with dysfunction of biological mitral valve prosthesis (valve-in-valve). A patient aged 78 years with a high surgical risk and severe heart failure due to mitral valve bioprosthesis dysfunction is described. Fluoroscopyand transesophageal echocardiography-guided transapical implantation of a MedLab-CT prosthesis (23 mm) was made. When a heart rate of 180 beats per minute, a stent prosthesis was implanted. Transcatheter implant valve functioned properly after surgery. The patient was discharged in satisfactory condition.